XWELL (STU:V9G0) Research & Development: €0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:V9G0 XWELL Inc STU:V9G0
27 GF Score
Price €2.96
GF Value €2.45
! 4 Warning Signs
View Full Analysis

What is XWELL Research & Development?

XWELL STU:V9G0 27 Research & Development is €0.00 Mil as of Jun. 2026. GuruFocus rates STU:V9G0 with a GF Score™ of 27/100 and a GF Value™ of €2.45. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. XWELL's Research & Development for the three months ended in Jun. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €0.00 Mil.

XWELL  (STU:V9G0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XWELL Research & Development Related Terms

XWELL Research & Development Historical Data

* Premium members only.

The historical data trend for XWELL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XWELL Research & Development Chart

XWELL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XWELL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:V9G0
27GF Score
XWELL Inc STU:V9G0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XWELL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
XWELL (STU:V9G0) has a Research & Development of €0.00 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on XWELL and its competitors.
Is XWELL's Research & Development too high?
XWELL's current Research & Development is €0.00 Mil. Overall, XWELL has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does XWELL's Research & Development compare to MBAI and NDRA?
XWELL's Research & Development of €0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on XWELL and its competitors. XWELL's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XWELL stock overvalued right now?
XWELL (STU:V9G0) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €2.45, compared to a current price of €2.96 — trading 20.8% above its estimated fair value. The current Research & Development is €0.00 Mil. XWELL's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For XWELL (STU:V9G0), the current Research & Development is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XWELL (STU:V9G0) Overvalued in 2026?

Based on GuruFocus' analysis, XWELL stock appears to be overvalued. The current stock price of €2.96 is trading 20.8% above its estimated GF Value™ of €2.45.

Key valuation signals for STU:V9G0:

  • Research & Development: €0.00 Mil
  • GF Value™: €2.45 vs. price of €2.96 (20.8% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the STU:V9G0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XWELL Business Description

Other Exchanges XWEL:USA
Address 254 West 31st Street, 11th Floor, New York, NY, USA, 10001
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.
27GF Score

Get the complete analysis for STU:V9G0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.96
Price
€2.45
GF Value